Executives

Cameron is an industry recognized innovator and expert in the field of breast Magnetic Resonance. He was awarded the 2008 Premier’s Catalyst Award for the Best Young Innovator of the Year' in Ontario, Canada. As a Masters student at Sunnybrook Health Sciences Centre, he developed Sentinelle’s core technology. This research spanned breast MRI techniques, interventional procedure software development and multi-modality technology. Radio Frequency coil development centered around a dedicated breast MR imaging and intervention table which is now the Vanguard® product. This research spawned four academic papers (two of which won international awards), 15 invited talks (two winning awards), 22 abstracts and the core IP to Sentinelle Medical®. To date, Cameron has developed or co-developed two patents (granted), as well as 19 that are filed and 10 provisional patents.

Prior to founding Sentinelle, Cameron concurrently worked as VP Research and Development for two small medical device companies, Samarit Medical and Pinel Medical, where he was involved in product development, manufacturing process definition, sales, service and marketing functions.

Cameron completed the Systems Design Engineering program at University of Waterloo specializing in medical imaging and carried research through the Medical Biophysics program at University of Toronto, Sunnybrook Campus.

Gal has over 11 years of experience working in research and new concept development in interventional radiology. Prior to joining Sentinelle Medical Gal worked as a self-employed contractor providing software solutions to radiological imaging researchers. Before that he was involved in the design and installation of a novel intra-operative neurosurgical MRI system at the Toronto Western Hospital, was an integral part of the neuro-surgical support team, and was the primary software developer for the neuro-navigation visualization and tracking software used. Gal was also a member of the Imaging Research group at Sunnybrook Hospital throughout that period where he worked on analysis methods for classifying and visualizing white matter diseases and treatment monitoring.

He has a Master’s degree in Electrical Engineering from McGill University specializing in image processing and machine vision and is named in over 15 publications and conference proceedings in interventional radiology.

Chris has entrepreneurial expertise and is a recognized innovator. As a founder of Sentinelle Medical, Chris has lead the mechanical design of the Vanguard System, leading to a number of key patents. He has managed the development of the Vanguard system from prototype to commercial production.

Prior to SMI, Chris founded and managed Centerline Designs. This initiative provided Chris with valuable small business startup experience designing, developing and manufacturing custom equipment for a variety of communities including environmental sciences, manufacturing, medical devices, and medical imaging research.

Chris also has many engineering firsts to his credit including the world’s first MRI-compatible microstepping motor. While working for the University of Toronto’s Department of Medical Biophysics, Chris helped develop a number of early stage technologies in medical imaging research, including minimally-invasive thermal therapy probes which use ultrasound to destroy diseased tissue without the need for surgical intervention. Chris has publications and patents on diverse subjects such as ultrasound frequency control, Magnetic Resonance Elastography, and MR-guided intervention.

Ian brings strong operating and financial leadership capabilities to Sentinelle. Most recently, he was Controller and then National Business Development manager for GE Healthcare Canada, a $400 million operating division of General Electric. GE Healthcare offers a broad array of healthcare technology products to the clinical, diagnostic imaging and healthcare IT markets, and Ian has leadership experience spanning the entire portfolio.

Prior to joining GE, Ian held numerous finance, business and technology development roles in the energy and manufacturing sectors. He has built strategic alliances with government agencies (including a $7 million technology demonstration project for advanced Liquid Natural Gas applications), led Merger and Acquisition projects, and has led the capital and strategic planning functions for a $3 billion energy company.

Ian holds Bachelors (Waterloo) and Masters (UBC) degrees in Engineering and an MBA from Wilfrid Laurier University where he graduated in 2005 as the Graduate Gold Medalist. He is a Professional Engineer, a Certified Management Accountant and currently serves on the Board Finance and Audit Committee for CMA Ontario.

Amol brings with him a broad experience in medical device companies from both a large corporation and a startup. Prior to joining Sentinelle, Amol was the Director of Business Development at Ultrasonix Medical Corporation, where he increased the OEM business over 400% over the last three years. He also established the Global Service business and as an Executive Manager of the company was involved in many facets as it went from a Research and Development business to a growing commercial entity. Distribution was set up in over 90 countries.

Prior to Ultrasonix, Amol was involved in Business Development and Integration at GE Healthcare in the Ultrasound division. He successfully brought in over $150 million in business through the integration of four companies into GE. Amol joined GE on the Technical Leadership Program, where he rotated though various departments at GE Healthcare.

Amol earned his Masters degree in Electrical Engineering from McGill University and his Bachelors in Electrical Engineering from the University of Waterloo.

Michelle is a proven business leader with extensive experience in both research and commercialization of breast imaging in the international market. Over the past 2 years, Michelle has helped to transition Sentinelle form a pure R&D company to a market focused organization. Prior to joining Sentinelle, Michelle spent two years in different marketing capacities with Guidant, a leading cardiac device manufacturer.

Michelle also brings significant healthcare start-up experience. She was an integral part of the sales, marketing and applications teams for two other Canadian healthcare start-up medical imaging companies. With VisualSonics, a leading developer of high-resolution imaging systems, she was involved in the successfully expansion of sales in North America, Europe, Asia and Australia from greenfield to over $22 million. With Hygeia, she helped grow the organization into a market-leading Preferred Provider Organization for major medical benefit plans.

Michelle began her research in breast imaging at the University of Toronto in the department of Medical Biophysics; an interdisciplinary research department focused on practical solution in cancer detection.

Paul brings to Sentinelle a wide range of experience from the healthcare and technology sectors. Most recently Paul was the Director of New Business – Diagnostics for McNeil (a Division of Johnson & Johnson). In this capacity, Paul was responsible for licensing and acquisitions of diagnostic and devices for McNeil Canada.

Prior to joining Johnson&Johnson, Paul was a Senior Director and Portfolio Manager for the Control Room and Portable Projection group of a high end projection manufacturer. In this capacity, Paul successfully drove portfolio strategy including internal product developments, OEM partnerships, marketing and channel support strategies. These efforts resulted in 50% growth in the Control Room market and growth from near greenfield, to $18 million in portable projection over a two year period.

Paul also brings significant start-up and commercialization experience. He founded and served as interim President and CEO of a privately held, angel backed organic juice company. In this capacity, he developed the strategy, raised investment capital and established the operating infrastructure. Paul also spent two years developing a Business Accelerator Program for Waterloo Region Technology Association. This organization worked with over 100 start-up technology companies, service providers and sources of capital and focused on commercialization and financing.

Brad contributes a successful track record as a Sales leader with 22 years at GE, with 17 of those in the Healthcare Division. His contributions in Sales and Marketing while at GE afforded him many accolades including being the top ranked sales representative in 1997 and 1998 setting new Corporate records of $47.0M and $54.0M respectively.  Notably, Brad was a top performer ranking in the top 5% of the Sales force for 12 of his 17 years.

Prior to joining Sentinelle, Brad led several field teams managing large Strategic, Corporate and Academic Accounts in the Southeastern USA. Brad was recognized during his last 8 years at GE for his efforts in sales training with GE’s New Hire program, supporting the field introduction and training of 23 new sales representatives.

Brad worked at GE Silicones, Plastics and Healthcare in Marketing, Field Sales and Leadership positions in Academic and Strategic Accounts. He also served as a liaison between GE and R&D partners working on scientific work scopes related to product development in PET-CT, digital mammography and breast MRI. Brad was an active member of the Atlanta Leadership Team and is Six Sigma trained.

With a B.S. in Chemical Engineering from the Florida Institute of Technology, and an extensive understanding of radiology, Brad brings both strong leadership and business acumen in the breast imaging industry in the United States.